COTY vs LRLCY: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: COTY is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. COTY and LRLCY share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined COTY and LRLCY exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Coty Inc is one of the world's largest beauty companies, operating through two reporting segments. Prestige, which makes up roughly 60% of sales, is anchored by licensed luxury fragrances (Burberry, Hugo Boss, Calvin Klein, Davidoff, Marc Jacobs, Chloe, and Gucci for now) plus owned or licensed makeup lines such as Kylie Cosmetics. Consumer Beauty covers mass-market cosmetics and skincare, including CoverGirl, Max Factor, Rimmel, Sally Hansen and Bourjois. The company was assembled largely through acquisitions, notably the 2016 purchase of Procter & Gamble beauty brands, which left it carrying a heavy debt load. Investment firm JAB remains the controlling shareholder with a majority stake, and Coty added a dual listing on the Paris Stock Exchange to broaden its investor base.

Full COTY guide

L'Oréal S.A. is a Paris-based beauty group with more than 35 international brands sold in about 150 countries. It makes money by selling skincare, makeup, hair care and fragrance through four divisions: Consumer Products (L'Oréal Paris, Maybelline, Garnier), the largest by sales; L'Oréal Luxe (Lancôme, Yves Saint Laurent Beauté, Armani, Prada, Valentino, Aesop and, since April 2026, Creed); Dermatological Beauty (La Roche-Posay, CeraVe, Vichy, SkinCeuticals); and Professional Products (Kérastase, Redken), sold through salons. The Bettencourt Meyers family owns roughly a third of the company and Nestlé about a fifth. LRLCY is an unsponsored ADR that trades in dollars and tracks the Euronext Paris share (ticker OR) adjusted for the euro-dollar rate.

Full LRLCY guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• COTY drivers: Prestige fragrance as the growth engine; Balance sheet repair and deleveraging.
• LRLCY drivers: Dermatological Beauty; Luxury fragrance and Kering Beauté.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The biggest risk is execution: Coty is mid-turnaround with declining like-for-like revenue, a fiscal 2026 net loss of about $618 million, and a Consumer Beauty business that took a large non-cash impairment. For LRLCY, valuation is the main risk.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick COTY if you believe its drivers more; LRLCY if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the COTY and LRLCY guides.

COTY. At about 0.5 times sales and roughly 13 times forward earnings, Coty is priced as a distressed turnaround rather than a steady beauty compounder, and the average analyst target of about $2.66 sits below the current price with a consensus hold rating. For the September quarter, due around November 5, 2026, analysts expect adjusted EPS of about $0.12 on roughly $1.53 billion of revenue, in line with management's 11-13 cent guide. Reported numbers have been distorted by one-time items such as the Wella disposal loss and the Consumer Beauty impairment, so always verify the latest quarterly release, balance sheet and any updated guidance from primary sources before making a decision.

LRLCY. L'Oréal has long traded at a premium to consumer-staples peers because of its steady growth and expanding margins. First-half 2026 net profit excluding one-off items was ~€3.96 billion, up 4.7%, and reported attributable net profit was ~€3.55 billion. LRLCY traded between about $78.82 and $95.48 over the past year. Analysts expect 2026 revenue of roughly €47.0 billion, up about 6.8%, and around €50.0 billion in 2027. The third-quarter sales release on October 22, 2026 (after the Paris close) is the next test of whether the faster first-half pace carried into the second half.

Headline figures (approximate, October 2026): COTY shows revenue (ttm) ~$5.8 billion (fiscal 2026, ended June 30), down ~1% from ~$5.9 billion, latest quarter (fiscal q4 2026) ~$1.27 billion revenue, +1% reported, -1% like-for-like; adjusted EPS -$0.02 vs ~-$0.01 expected, margins Gross ~63%; operating ~-2%; net ~-10% (TTM), net income (ttm) ~-$618 million (loss, including impairments); LRLCY shows revenue (ttm) ~€45.4 billion (~$53 billion), h1 2026 sales growth (like-for-like) ~6.8% (Q2 alone ~6.0%), operating margin (h1 2026) ~21.3%, a first-half record, market cap ~$242 billion.

COTY and LRLCY are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined COTY and LRLCY exposure against your real portfolio. It is not an investment adviser.